Medicure (OTCMKTS:MCUJF) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

Shares of Medicure Inc. (OTCMKTS:MCUJFGet Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.83 and traded as low as $0.8164. Medicure shares last traded at $0.8164, with a volume of 125 shares trading hands.

Medicure Stock Performance

The firm has a market cap of $8.52 million, a P/E ratio of -1.74 and a beta of 0.98. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The stock’s 50-day moving average is $0.83 and its 200 day moving average is $0.83.

Medicure (OTCMKTS:MCUJFGet Free Report) last announced its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. The company had revenue of $5.79 million during the quarter, compared to the consensus estimate of $3.63 million. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.

About Medicure

(Get Free Report)

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.

Read More

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.